Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
Conversation with The Cancer Letter

Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements

Christopher Li, the Helen G. Edson Endowed Chair for Breast Cancer Research at Fred Hutchinson Cancer Center, understands what it means to be an underrepresented minority at each stage of his academic career.
June 07, 2024
Vol.50 No.23
By Matthew Bin Han Ong
Richard Simon, NCI’s visionary biostatistician, dies at 80
Obituary

Richard Simon, NCI’s visionary biostatistician, dies at 80

Richard M. Simon, NCI biostatistician who likely set a record for the number of first-authored papers, and whose interests included country music, horseback riding and ballroom dancing, died May 9, at age 80. Simon joined NCI in 1974.
May 24, 2024
Vol.50 No.21
By Paul Goldberg
As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25
Capitol Hill

As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25

NCI Director Kimryn Rathmell joined the NIH director and four other institute directors in a May 23 Senate subcommittee hearing to craft the Labor-HHS spending bill for fiscal year 2025.
May 24, 2024
Vol.50 No.21
By McKenzie Prillaman
NCI: Cancer center communicators are key to the success of the National Cancer Plan

NCI: Cancer center communicators are key to the success of the National Cancer Plan

Cancer center communicators—public relations, marketing, and communications experts—are indispensable players in the implementation of the National Cancer Plan, said Peter Garrett, director of NCI’s Office of Communications and Public Liaison.
May 24, 2024
Vol.50 No.21
By Jacquelyn Cobb
Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity
Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Tumor heterogeneity is a well-recognized hurdle to successful cancer therapy, often leading to resistance and treatment failure. 
May 10, 2024
Vol.50 No.19
By Sanju Sinha and Eytan Ruppin
In Brief

NCI renews MUSC Hollings support grant with “outstanding” rating

NCI has renewed MUSC Hollings Cancer Center’s five-year Cancer Center Support Grant, with an overall rating of “outstanding.”
April 19, 2024
Vol.50 No.16
Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
April 12, 2024
Vol.50 No.15
By Jacquelyn Cobb
Rathmell: To improve funding outlook, we must reverse distrust in science
NCI

Rathmell: To improve funding outlook, we must reverse distrust in science

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.
April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong
NCI creates Cancer Equity Leaders group to improve cancer health equity
Health Equity

NCI creates Cancer Equity Leaders group to improve cancer health equity

To address inequities in cancer health, NCI is collaborating with a diverse team of experts and cancer center directors—named the Cancer Equity Leaders (CEL)—to learn from communities and inform workforce development as well as outreach initiatives.
April 12, 2024
Vol.50 No.15
By Matthew Bin Han Ong
NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

NCI is lowering paylines for R01 grants for established and new investigators to the 10th percentile, down from the 12th percentile in FY23.
April 05, 2024
Vol.50 No.14
By Matthew Bin Han Ong

Posts navigation

Previous1…141516…36Next

Trending Stories

  • How George Tidmarsh crossed the FDA-industry Rubicon
  • CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
    Cancer advocates express concern about comments that signal trouble for accelerated approval
  • Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
  • City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure
  • Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
  • Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account